|Articles|July 1, 2005

Pharmacy Times

  • Volume 0
  • 0

Biotech Companies Experience Growth

The biotechnology industry is cominginto its own, according to BeyondBorders, Ernst & Young's 19th AnnualGlobal Biotechnology report. Withgovernmental support and private capital,biotech companies worldwide aretranslating cutting-edge science intolife-improving therapies. The industry'ssuccess in 2004 included:

  • The approval of 20 new biotechmedicines in the United States.
  • Biotech companies now marketapproximately 230 drugs, including13 therapeutic antibodies. Inaddition, 55 new drug applicationsawait approval in the UnitedStates alone.

"Biotech innovation is a key valuedriver for the pharmaceutical industry,as more than half of its late-stagepipeline now consists of therapeuticsgenerated using biotechnology advances,"said Mike Hildreth, Americasdirector, biotechnology, Ernst &Young.

Articles in this issue

over 20 years ago

Calcium: An Essential Mineral

over 20 years ago

CAN YOU READTHESE Rxs?

over 20 years ago

ECKEL RECEIVES ALUMNI AWARD

over 20 years ago

Cancer: Update on Biologics

over 20 years ago

PHARMACIST'S RIGHT TO CHOOSE?

over 20 years ago

Teenage Drug Diversion—Part 2

over 20 years ago

Is Altering Refills a Criminal Act?

over 20 years ago

Do All SSRIs Interact the Same Way?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME